ID   ILK_HUMAN               Reviewed;         452 AA.
AC   Q13418; B7Z1I0; B7Z418; D3DQU0; P57043; Q68DZ3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 2.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=Integrin-linked protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=59 kDa serine/threonine-protein kinase;
DE   AltName: Full=ILK-1;
DE   AltName: Full=ILK-2;
DE   AltName: Full=p59ILK;
GN   Name=ILK; Synonyms=ILK1, ILK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=8538749; DOI=10.1038/379091a0;
RA   Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G.,
RA   Radeva G., Filmus J., Bell J.C., Dedhar S.;
RT   "Regulation of cell adhesion and anchorage-dependent growth by a new
RT   beta 1-integrin-linked protein kinase.";
RL   Nature 379:91-96(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10871859; DOI=10.1038/sj.onc.1203640;
RA   Janji B., Melchior C., Vallar L., Kieffer N.;
RT   "Cloning of an isoform of integrin-linked kinase (ILK) that is
RT   upregulated in HT-144 melanoma cells following TGF-beta1
RT   stimulation.";
RL   Oncogene 19:3069-3077(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tadic B., Hannigan G.E.;
RT   "Integrin-linked kinase genomic sequence.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Melchior C., Janji B., Kreis S., Kieffer N.;
RT   "Structural organisation of the gene encoding integrin-linked kinase
RT   1.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Cerebellum, and Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF GLU-359.
RX   PubMed=9736715; DOI=10.1073/pnas.95.19.11211;
RA   Delcommenne M., Tan C., Gray V., Rue L., Woodgett J.R., Dedhar S.;
RT   "Phosphoinositide-3-OH kinase-dependent regulation of glycogen
RT   synthase kinase 3 and protein kinase B/AKT by the integrin-linked
RT   kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216(1998).
RN   [12]
RP   REVIEW.
RX   PubMed=10712922; DOI=10.1016/S0955-0674(99)00083-6;
RA   Dedhar S.;
RT   "Cell-substrate interactions and signaling through ILK.";
RL   Curr. Opin. Cell Biol. 12:250-256(2000).
RN   [13]
RP   INTERACTION WITH PARVB, AND SUBCELLULAR LOCATION.
RX   PubMed=11402068; DOI=10.1083/jcb.153.6.1251;
RA   Yamaji S., Suzuki A., Sugiyama Y., Koide Y., Yoshida M., Kanamori H.,
RA   Mohri H., Ohno S., Ishigatsubo Y.;
RT   "A novel integrin-linked kinase-binding protein, affixin, is involved
RT   in the early stage of cell-substrate interaction.";
RL   J. Cell Biol. 153:1251-1264(2001).
RN   [14]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH LIMS1 AND LIMS2.
RX   PubMed=12167643; DOI=10.1074/jbc.M205576200;
RA   Zhang Y., Chen K., Guo L., Wu C.;
RT   "Characterization of PINCH-2, a new focal adhesion protein that
RT   regulates the PINCH-1-ILK interaction, cell spreading, and
RT   migration.";
RL   J. Biol. Chem. 277:38328-38338(2002).
RN   [15]
RP   INTERACTION WITH PARVA AND PARVB.
RX   PubMed=15284246; DOI=10.1074/jbc.M401563200;
RA   Zhang Y., Chen K., Tu Y., Wu C.;
RT   "Distinct roles of two structurally closely related focal adhesion
RT   proteins, alpha-parvins and beta-parvins, in regulation of cell
RT   morphology and survival.";
RL   J. Biol. Chem. 279:41695-41705(2004).
RN   [16]
RP   INTERACTION WITH EPHA1.
RX   PubMed=19118217; DOI=10.1242/jcs.036467;
RA   Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y.;
RT   "EphA1 interacts with integrin-linked kinase and regulates cell
RT   morphology and motility.";
RL   J. Cell Sci. 122:243-255(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   INTERACTION WITH LIMD2, AND ENZYME REGULATION.
RX   PubMed=24590809; DOI=10.1158/0008-5472.CAN-13-1275;
RA   Peng H., Talebzadeh-Farrooji M., Osborne M.J., Prokop J.W.,
RA   McDonald P.C., Karar J., Hou Z., He M., Kebebew E., Orntoft T.,
RA   Herlyn M., Caton A.J., Fredericks W., Malkowicz B., Paterno C.S.,
RA   Carolin A.S., Speicher D.W., Skordalakes E., Huang Q., Dedhar S.,
RA   Borden K.L., Rauscher F.J. III;
RT   "LIMD2 is a small LIM-only protein overexpressed in metastatic lesions
RT   that regulates cell motility and tumor progression by directly binding
RT   to and activating the integrin-linked kinase.";
RL   Cancer Res. 74:1390-1403(2014).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-174 IN COMPLEX WITH LIMS1,
RP   DOMAIN ANK REPEATS, AND MUTAGENESIS OF HIS-99.
RX   PubMed=19074270; DOI=10.1073/pnas.0811415106;
RA   Chiswell B.P., Zhang R., Murphy J.W., Boggon T.J., Calderwood D.A.;
RT   "The structural basis of integrin-linked kinase-PINCH interactions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:20677-20682(2008).
RN   [24]
RP   STRUCTURE BY NMR OF 1-171 IN COMPLEX WITH LIMS1, AND DOMAIN ANK
RP   REPEATS.
RX   PubMed=19117955; DOI=10.1074/jbc.M805319200;
RA   Yang Y., Wang X., Hawkins C.A., Chen K., Vaynberg J., Mao X., Tu Y.,
RA   Zuo X., Wang J., Wang Y.-X., Wu C., Tjandra N., Qin J.;
RT   "Structural basis of focal adhesion localization of LIM-only adaptor
RT   PINCH by integrin-linked kinase.";
RL   J. Biol. Chem. 284:5836-5844(2009).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 183-452 IN COMPLEX WITH
RP   PARVA, AND INTERACTION WITH PARVA.
RX   PubMed=20005845; DOI=10.1016/j.molcel.2009.11.028;
RA   Fukuda K., Gupta S., Chen K., Wu C., Qin J.;
RT   "The pseudoactive site of ILK is essential for its binding to alpha-
RT   parvin and localization to focal adhesions.";
RL   Mol. Cell 36:819-830(2009).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 183-452 IN COMPLEX WITH
RP   PARVA, AND INTERACTION WITH PARVA.
RX   PubMed=20117114; DOI=10.1016/j.jmb.2010.01.048;
RA   Im Y.J., Kang G.B., Lee J.H., Park K.R., Song H.E., Kim E., Song W.K.,
RA   Park D., Eom S.H.;
RT   "Structural basis for asymmetric association of the betaPIX coiled
RT   coil and shank PDZ.";
RL   J. Mol. Biol. 397:457-466(2010).
RN   [27]
RP   VARIANT VAL-262.
RX   PubMed=17646580; DOI=10.1161/CIRCULATIONAHA.107.689984;
RA   Knoell R., Postel R., Wang J., Kraetzner R., Hennecke G., Vacaru A.M.,
RA   Vakeel P., Schubert C., Murthy K., Rana B.K., Kube D., Knoell G.,
RA   Schaefer K., Hayashi T., Holm T., Kimura A., Schork N., Toliat M.R.,
RA   Nuernberg P., Schultheiss H.P., Schaper W., Schaper J., Bos E.,
RA   Den Hertog J., van Eeden F.J., Peters P.J., Hasenfuss G., Chien K.R.,
RA   Bakkers J.;
RT   "Laminin-alpha4 and integrin-linked kinase mutations cause human
RT   cardiomyopathy via simultaneous defects in cardiomyocytes and
RT   endothelial cells.";
RL   Circulation 116:515-525(2007).
CC   -!- FUNCTION: Receptor-proximal protein kinase regulating integrin-
CC       mediated signal transduction (PubMed:8538749, PubMed:9736715). May
CC       act as a mediator of inside-out integrin signaling. Focal adhesion
CC       protein part of the complex ILK-PINCH. This complex is considered
CC       to be one of the convergence points of integrin- and growth
CC       factor-signaling pathway. Could be implicated in mediating cell
CC       architecture, adhesion to integrin substrates and anchorage-
CC       dependent growth in epithelial cells. Phosphorylates beta-1 and
CC       beta-3 integrin subunit on serine and threonine residues, but also
CC       AKT1 and GSK3B (PubMed:8538749, PubMed:9736715).
CC       {ECO:0000269|PubMed:8538749, ECO:0000269|PubMed:9736715,
CC       ECO:0000303|PubMed:10712922}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Stimulated rapidly but transiently by both cell
CC       fibronectin interactions, as well as by insulin, in a PI3-K-
CC       dependent manner, likely via the binding of PtdIns(3,4,5)P3 with a
CC       PH-like domain of ILK. The protein kinase activity is stimulated
CC       by LIMD2 (PubMed:24590809). {ECO:0000269|PubMed:24590809}.
CC   -!- SUBUNIT: Interacts with FERMT2 (By similarity). Interacts with the
CC       cytoplasmic domain of ITGB1. Could also interact with integrin
CC       ITGB2, ITGB3 and/or ITGB5. Interacts (via ANK repeats) with LIMS1
CC       and LIMS2. Interacts with PARVA and PARVB; these compete for the
CC       same binding site. Interacts probably also with TGFB1I1. Interacts
CC       (via ANK repeats) with EPHA1 (via SAM domain); stimulated by EFNA1
CC       but independent of the kinase activity of EPHA1. Interacts with
CC       LIMD2; leading to activate the protein kinase activity
CC       (PubMed:24590809). {ECO:0000250, ECO:0000269|PubMed:11402068,
CC       ECO:0000269|PubMed:12167643, ECO:0000269|PubMed:15284246,
CC       ECO:0000269|PubMed:19074270, ECO:0000269|PubMed:19117955,
CC       ECO:0000269|PubMed:19118217, ECO:0000269|PubMed:20005845,
CC       ECO:0000269|PubMed:20117114, ECO:0000269|PubMed:24590809}.
CC   -!- INTERACTION:
CC       Q14790:CASP8; NbExp=2; IntAct=EBI-747644, EBI-78060;
CC       P55211:CASP9; NbExp=2; IntAct=EBI-747644, EBI-516799;
CC       Q9H0C8:ILKAP; NbExp=3; IntAct=EBI-747644, EBI-2620298;
CC       P48059:LIMS1; NbExp=7; IntAct=EBI-747644, EBI-306928;
CC       Q9NVD7:PARVA; NbExp=14; IntAct=EBI-747644, EBI-747655;
CC       Q9HBI0:PARVG; NbExp=9; IntAct=EBI-747644, EBI-3921217;
CC       Q6R327:RICTOR; NbExp=8; IntAct=EBI-747644, EBI-1387196;
CC       Q9BWU0:SLC4A1AP; NbExp=8; IntAct=EBI-747644, EBI-1999704;
CC       Q9UMS6:SYNPO2; NbExp=6; IntAct=EBI-747644, EBI-3453434;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-747644, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:11402068, ECO:0000269|PubMed:12167643}. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side
CC       {ECO:0000269|PubMed:11402068}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:O55222}. Cytoplasm, myofibril, sarcomere
CC       {ECO:0000269|PubMed:11402068}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q13418-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13418-2; Sequence=VSP_054920;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q13418-3; Sequence=VSP_055925;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart followed by skeletal
CC       muscle, pancreas and kidney. Weakly expressed in placenta, lung
CC       and liver.
CC   -!- DOMAIN: A PH-like domain is involved in phosphatidylinositol
CC       phosphate binding. {ECO:0000269|PubMed:19074270,
CC       ECO:0000269|PubMed:19117955}.
CC   -!- PTM: Autophosphorylated on serine residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB94832.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact. Was originally thought to be distinct gene (ILK2) (PubMed:10871859).; Evidence={ECO:0000305|PubMed:10871859};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40282; AAC16892.1; -; mRNA.
DR   EMBL; AJ277481; CAB94832.1; ALT_SEQ; mRNA.
DR   EMBL; AF244139; AAF74449.1; -; Genomic_DNA.
DR   EMBL; AJ404847; CAB99253.1; -; Genomic_DNA.
DR   EMBL; AK293474; BAH11516.1; -; mRNA.
DR   EMBL; AK296628; BAH12404.1; -; mRNA.
DR   EMBL; CR407673; CAG28601.1; -; mRNA.
DR   EMBL; CR749220; CAH18077.1; -; mRNA.
DR   EMBL; AC091564; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68688.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68689.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68690.1; -; Genomic_DNA.
DR   EMBL; BC001554; AAH01554.1; -; mRNA.
DR   CCDS; CCDS60712.1; -. [Q13418-2]
DR   CCDS; CCDS60713.1; -. [Q13418-3]
DR   CCDS; CCDS7768.1; -. [Q13418-1]
DR   PIR; S68455; S68455.
DR   RefSeq; NP_001014794.1; NM_001014794.2. [Q13418-1]
DR   RefSeq; NP_001014795.1; NM_001014795.2. [Q13418-1]
DR   RefSeq; NP_001265370.1; NM_001278441.1. [Q13418-2]
DR   RefSeq; NP_001265371.1; NM_001278442.1. [Q13418-3]
DR   RefSeq; NP_004508.1; NM_004517.3. [Q13418-1]
DR   RefSeq; XP_005252961.1; XM_005252904.4. [Q13418-1]
DR   RefSeq; XP_005252962.1; XM_005252905.2. [Q13418-3]
DR   RefSeq; XP_011518367.1; XM_011520065.1. [Q13418-1]
DR   UniGene; Hs.706355; -.
DR   PDB; 2KBX; NMR; -; A=1-171.
DR   PDB; 3F6Q; X-ray; 1.60 A; A=1-170.
DR   PDB; 3IXE; X-ray; 1.90 A; A=1-174.
DR   PDB; 3KMU; X-ray; 1.80 A; A=183-452.
DR   PDB; 3KMW; X-ray; 2.00 A; A=183-452.
DR   PDB; 3REP; X-ray; 1.80 A; A=183-452.
DR   PDB; 4HI8; X-ray; 1.20 A; A=1-174.
DR   PDB; 4HI9; X-ray; 1.20 A; A=1-174.
DR   PDBsum; 2KBX; -.
DR   PDBsum; 3F6Q; -.
DR   PDBsum; 3IXE; -.
DR   PDBsum; 3KMU; -.
DR   PDBsum; 3KMW; -.
DR   PDBsum; 3REP; -.
DR   PDBsum; 4HI8; -.
DR   PDBsum; 4HI9; -.
DR   ProteinModelPortal; Q13418; -.
DR   SMR; Q13418; -.
DR   BioGrid; 109824; 214.
DR   DIP; DIP-38657N; -.
DR   IntAct; Q13418; 178.
DR   MINT; MINT-1465247; -.
DR   STRING; 9606.ENSP00000299421; -.
DR   BindingDB; Q13418; -.
DR   ChEMBL; CHEMBL5247; -.
DR   GuidetoPHARMACOLOGY; 2041; -.
DR   iPTMnet; Q13418; -.
DR   PhosphoSitePlus; Q13418; -.
DR   SwissPalm; Q13418; -.
DR   DMDM; 9973397; -.
DR   OGP; Q13418; -.
DR   EPD; Q13418; -.
DR   PaxDb; Q13418; -.
DR   PeptideAtlas; Q13418; -.
DR   PRIDE; Q13418; -.
DR   DNASU; 3611; -.
DR   Ensembl; ENST00000299421; ENSP00000299421; ENSG00000166333. [Q13418-1]
DR   Ensembl; ENST00000396751; ENSP00000379975; ENSG00000166333. [Q13418-1]
DR   Ensembl; ENST00000420936; ENSP00000403487; ENSG00000166333. [Q13418-1]
DR   Ensembl; ENST00000528995; ENSP00000435323; ENSG00000166333. [Q13418-2]
DR   Ensembl; ENST00000532063; ENSP00000434492; ENSG00000166333. [Q13418-3]
DR   GeneID; 3611; -.
DR   KEGG; hsa:3611; -.
DR   UCSC; uc010rap.3; human. [Q13418-1]
DR   CTD; 3611; -.
DR   DisGeNET; 3611; -.
DR   GeneCards; ILK; -.
DR   HGNC; HGNC:6040; ILK.
DR   HPA; CAB004041; -.
DR   HPA; HPA048437; -.
DR   MIM; 602366; gene.
DR   neXtProt; NX_Q13418; -.
DR   OpenTargets; ENSG00000166333; -.
DR   PharmGKB; PA29855; -.
DR   eggNOG; KOG0195; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00760000118807; -.
DR   HOGENOM; HOG000047828; -.
DR   HOVERGEN; HBG002437; -.
DR   InParanoid; Q13418; -.
DR   KO; K06272; -.
DR   PhylomeDB; Q13418; -.
DR   TreeFam; TF315194; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-446343; Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
DR   Reactome; R-HSA-446353; Cell-extracellular matrix interactions.
DR   SignaLink; Q13418; -.
DR   SIGNOR; Q13418; -.
DR   ChiTaRS; ILK; human.
DR   EvolutionaryTrace; Q13418; -.
DR   GeneWiki; Integrin-linked_kinase; -.
DR   GenomeRNAi; 3611; -.
DR   PRO; PR:Q13418; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000166333; -.
DR   CleanEx; HS_ILK; -.
DR   ExpressionAtlas; Q13418; baseline and differential.
DR   Genevisible; Q13418; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0043034; C:costamere; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043198; C:dendritic shaft; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR   GO; GO:0001725; C:stress fiber; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0004871; F:signal transducer activity; IBA:GO_Central.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0007569; P:cell aging; IEA:Ensembl.
DR   GO; GO:0007050; P:cell cycle arrest; IEA:Ensembl.
DR   GO; GO:0034329; P:cell junction assembly; TAS:Reactome.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:ProtInc.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0010761; P:fibroblast migration; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0000165; P:MAPK cascade; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0032288; P:myelin assembly; IEA:Ensembl.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0021675; P:nerve development; IEA:Ensembl.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0070527; P:platelet aggregation; IMP:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IEA:Ensembl.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IMP:CAFA.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IMP:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0043491; P:protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   GO; GO:0097435; P:supramolecular fiber organization; IEA:Ensembl.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:CAFA.
DR   Gene3D; 1.25.40.20; -; 2.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ANK repeat;
KW   ATP-binding; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasm; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    452       Integrin-linked protein kinase.
FT                                /FTId=PRO_0000086020.
FT   REPEAT        2     30       ANK 1.
FT   REPEAT       31     63       ANK 2.
FT   REPEAT       64     96       ANK 3.
FT   REPEAT       97    129       ANK 4.
FT   REPEAT      130    174       ANK 5.
FT   DOMAIN      193    446       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     199    207       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION       33    139       Interaction with LIMS1.
FT                                {ECO:0000269|PubMed:12167643}.
FT   REGION      180    212       PH-like; mediates interaction with
FT                                TGFB1I1.
FT   BINDING     220    220       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     426    426       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O55222}.
FT   VAR_SEQ       1    134       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055925.
FT   VAR_SEQ     118    206       DLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQN
FT                                LNRIPYKDTFWKGTTRTRPRNGTLNKHSGIDFKQLNFLTKL
FT                                NENHSGE -> SGQRRWARISTVFHTRTHSGRGPPALGP
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054920.
FT   VARIANT     262    262       A -> V (found in a patient with severe
FT                                dilated cardiomyopathy; unknown
FT                                pathological significance;
FT                                dbSNP:rs387907366).
FT                                {ECO:0000269|PubMed:17646580}.
FT                                /FTId=VAR_069753.
FT   MUTAGEN      99     99       H->D: Alters interaction with LIMS1.
FT                                {ECO:0000269|PubMed:19074270}.
FT   MUTAGEN     359    359       E->K: Inactivation of ILK.
FT                                {ECO:0000269|PubMed:9736715}.
FT   HELIX         4     10       {ECO:0000244|PDB:4HI8}.
FT   HELIX        13     21       {ECO:0000244|PDB:4HI8}.
FT   HELIX        37     43       {ECO:0000244|PDB:4HI8}.
FT   HELIX        47     55       {ECO:0000244|PDB:4HI8}.
FT   HELIX        70     76       {ECO:0000244|PDB:4HI8}.
FT   HELIX        80     88       {ECO:0000244|PDB:4HI8}.
FT   HELIX        92     94       {ECO:0000244|PDB:2KBX}.
FT   HELIX       103    109       {ECO:0000244|PDB:4HI8}.
FT   HELIX       113    121       {ECO:0000244|PDB:4HI8}.
FT   STRAND      126    128       {ECO:0000244|PDB:4HI8}.
FT   STRAND      131    133       {ECO:0000244|PDB:2KBX}.
FT   HELIX       136    139       {ECO:0000244|PDB:4HI8}.
FT   HELIX       142    154       {ECO:0000244|PDB:4HI8}.
FT   TURN        167    169       {ECO:0000244|PDB:4HI9}.
FT   HELIX       190    192       {ECO:0000244|PDB:3KMU}.
FT   STRAND      194    202       {ECO:0000244|PDB:3KMU}.
FT   STRAND      205    212       {ECO:0000244|PDB:3KMU}.
FT   STRAND      215    222       {ECO:0000244|PDB:3KMU}.
FT   HELIX       229    238       {ECO:0000244|PDB:3KMU}.
FT   HELIX       239    242       {ECO:0000244|PDB:3KMU}.
FT   STRAND      255    257       {ECO:0000244|PDB:3KMU}.
FT   TURN        259    261       {ECO:0000244|PDB:3KMU}.
FT   STRAND      262    264       {ECO:0000244|PDB:3KMU}.
FT   STRAND      266    270       {ECO:0000244|PDB:3KMU}.
FT   HELIX       277    282       {ECO:0000244|PDB:3KMU}.
FT   HELIX       291    308       {ECO:0000244|PDB:3KMU}.
FT   STRAND      311    313       {ECO:0000244|PDB:3KMU}.
FT   STRAND      324    327       {ECO:0000244|PDB:3KMU}.
FT   STRAND      333    336       {ECO:0000244|PDB:3KMU}.
FT   HELIX       337    339       {ECO:0000244|PDB:3KMU}.
FT   HELIX       353    355       {ECO:0000244|PDB:3KMU}.
FT   HELIX       358    362       {ECO:0000244|PDB:3KMU}.
FT   HELIX       365    367       {ECO:0000244|PDB:3KMU}.
FT   HELIX       370    387       {ECO:0000244|PDB:3KMU}.
FT   TURN        391    394       {ECO:0000244|PDB:3KMU}.
FT   HELIX       397    406       {ECO:0000244|PDB:3KMU}.
FT   HELIX       419    428       {ECO:0000244|PDB:3KMU}.
FT   HELIX       433    435       {ECO:0000244|PDB:3KMU}.
FT   HELIX       439    449       {ECO:0000244|PDB:3KMU}.
SQ   SEQUENCE   452 AA;  51419 MW;  E37DC2AD5311A1C2 CRC64;
     MDDIFTQCRE GNAVAVRLWL DNTENDLNQG DDHGFSPLHW ACREGRSAVV EMLIMRGARI
     NVMNRGDDTP LHLAASHGHR DIVQKLLQYK ADINAVNEHG NVPLHYACFW GQDQVAEDLV
     ANGALVSICN KYGEMPVDKA KAPLRELLRE RAEKMGQNLN RIPYKDTFWK GTTRTRPRNG
     TLNKHSGIDF KQLNFLTKLN ENHSGELWKG RWQGNDIVVK VLKVRDWSTR KSRDFNEECP
     RLRIFSHPNV LPVLGACQSP PAPHPTLITH WMPYGSLYNV LHEGTNFVVD QSQAVKFALD
     MARGMAFLHT LEPLIPRHAL NSRSVMIDED MTARISMADV KFSFQCPGRM YAPAWVAPEA
     LQKKPEDTNR RSADMWSFAV LLWELVTREV PFADLSNMEI GMKVALEGLR PTIPPGISPH
     VCKLMKICMN EDPAKRPKFD MIVPILEKMQ DK
//
